U.s. federal circuit court of appeals rules in favor of regeneron and sanofi in praluent® (alirocumab) patent litigation

Tarrytown, n.y., feb. 11, 2021 /prnewswire/ -- upholds decision by u.s. district court to invalidate amgen's patent claims directed to pcsk9 antibodies regeneron pharmaceuticals, inc. (nasdaq: regn) today announced that the united states court of appeals for the federal circuit upheld the...

REGN Ratings Summary

REGN Quant Ranking